Showing results (201-210 of 347) with videos related to
Sort By:
Pageof 35
Transplantation|January 15, 2013
Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal diseaseC Daniel Mullins, Rahul Jain, Matthew R Weir, et al.American Journal of Nephrology|July 9, 2004
Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant functionMatthew R Weir, Steven Blahut, Cinthia Drachenburg, et al.Archives of Internal Medicine|June 24, 2009
The frequency of hyperkalemia and its significance in chronic kidney diseaseLisa M Einhorn, Min Zhan, Van Doren Hsu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2015
Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and DimethylargininesAyse L Mindikoglu, Thomas C Dowling, Laurence S Magder, et al.Transplantation|December 11, 2012
Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsiesJohn C Papadimitriou, Cinthia B Drachenberg, Emilio Ramos, et al.Journal of Hypertension|June 12, 2009
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL studyHenry Krum, Gary Swergold, Sean P Curtis, et al.Kidney International|May 31, 2019
Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamicsGert J Mayer, Christoph Wanner, Matthew R Weir, et al.Kidney International|September 17, 2015
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemiaDavid A Bushinsky, Gordon H Williams, Bertram Pitt, et al.Transplantation|October 14, 2004
BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppressionRavinder K Wali, Cinthia Drachenberg, Hans H Hirsch, et al.European Heart Journal|December 30, 2021
Kidney function assessment and endpoint ascertainment in clinical trialsMuhammad Shahzeb Khan, George L Bakris, Milton Packer, et al.Pageof 35